생화학 시약 시장 : 제품 유형별, 최종 사용자별 - 세계 예측(2025-2030년)

The Biochemical Reagents Market was valued at USD 15.87 billion in 2023, expected to reach USD 16.85 billion in 2024, and is projected to grow at a CAGR of 6.48%, to USD 24.64 billion by 2030.

Biochemical reagents constitute a diverse array of substances essential for facilitating chemical reactions in bioscientific research and manufacturing processes. Defined as substances used in various chemical analyses and experiments, their scope extends across pharmaceuticals, biotechnology, and life sciences, playing a critical role in diagnostics, drug development, and genetic engineering. The necessity of biochemical reagents is underscored by the accelerating advancements in molecular biology and personalized medicine, where accurate and efficient biochemical assays are indispensable. These reagents find application in critical processes such as DNA sequencing, cell culture, and chromatography, with end-use spanning pharmaceuticals, research labs, clinical diagnostics, and academia. Key growth influences encompass the surging demand for innovative drugs, the expansion of biopharmaceutical sectors, and rising research funding in life sciences. Additionally, the increasing prevalence of chronic and infectious diseases drives the demand for more precise diagnostic solutions utilizing biochemical reagents. Emerging opportunities lie in bioinformatics and proteomics, where the development of high-specificity reagents could revolutionize data accuracy and efficacy. Recommendations to seize such opportunities include strategic partnerships between reagent manufacturers and tech companies for advanced research tools development. However, this market faces limitations like stringent regulatory frameworks, high costs of advanced reagents, and heightened competition leading to price wars. Additionally, technological obsolescence poses significant challenges, where rapid advancements can outdate existing reagents quickly. Innovation should focus on the integration of AI and machine learning to enhance reagent precision and utility, particularly within synthetic biology and personalized medicine sectors. The market reveals a diverse yet highly competitive nature, requiring robust research and strategic foresight to leverage innovation and sustain growth amidst challenges. By focusing on the synthesis of scalable, cost-effective, and multifunctional reagents, companies can foster greater adaptability and resilience in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biochemical Reagents Market

The Biochemical Reagents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing adoption of biochemical reagents for next-generation gene sequencing and polymerase chain reaction
  • Rise in the incidences of chronic diseases globally
  • Expanding the application of biochemical reagents in the healthcare and life science sectors
• Market Restraints
  • High cost associated with the development of biochemical reagents
• Market Opportunities
  • Increasing initiatives and funding for research and development activities for biochemical reagents by the governments and biotechnological firms
  • Growing stem cell research to assess the toxicity of medications
• Market Challenges
  • Strict regulations for the approval of the development of biochemical reagents

Porter's Five Forces: A Strategic Tool for Navigating the Biochemical Reagents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biochemical Reagents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biochemical Reagents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biochemical Reagents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biochemical Reagents Market

A detailed market share analysis in the Biochemical Reagents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biochemical Reagents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biochemical Reagents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biochemical Reagents Market

A strategic analysis of the Biochemical Reagents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biochemical Reagents Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alpha Teknova, Inc., AquaPhoenix Scientific, LLC., Becton, Dickinson and Company., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux, Inc., Biotron Diagnostics Inc., Danaher Corporation, ERBA Diagnostics Mannheim, Euroclone S.p.A., Genelinx International, Inc., LI-COR, Inc., d/b/a LI-COR Biosciences, Lonza Group Ltd., Merck KGaA, Promega Corporation, ProteoChem, Inc., Quality Biological, Inc., Revvity, Inc., Siemens Healthineers AG, Sysmex Asia Pacific Pte Ltd., Takara Bio USA, Inc., Thermo Fisher Scientific Inc., Viagen Biotech, Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Biochemical Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Cell & Tissue Culture Reagents, Chromatography Reagents, Electrophoresis Reagents, and Polymerase Chain Reaction (PCR) Reagent Kits.
• Based on End-user, market is studied across Academics & Research, Contract Research Organizations (CROs), Diagnostic Centers, Hospitals, and Pharma & Biotech Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing adoption of biochemical reagents for next-generation gene sequencing and polymerase chain reaction
    • 5.1.1.2. Rise in the incidences of chronic diseases globally
    • 5.1.1.3. Expanding the application of biochemical reagents in the healthcare and life science sectors
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the development of biochemical reagents
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing initiatives and funding for research and development activities for biochemical reagents by the governments and biotechnological firms
    • 5.1.3.2. Growing stem cell research to assess the toxicity of medications
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulations for the approval of the development of biochemical reagents
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biochemical Reagents Market, by Product Type

• 6.1. Introduction
• 6.2. Cell & Tissue Culture Reagents
• 6.3. Chromatography Reagents
• 6.4. Electrophoresis Reagents
• 6.5. Polymerase Chain Reaction (PCR) Reagent Kits

7. Biochemical Reagents Market, by End-user

• 7.1. Introduction
• 7.2. Academics & Research
• 7.3. Contract Research Organizations (CROs)
• 7.4. Diagnostic Centers
• 7.5. Hospitals
• 7.6. Pharma & Biotech Companies

8. Americas Biochemical Reagents Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biochemical Reagents Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biochemical Reagents Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Alpha Teknova, Inc.
• 3. AquaPhoenix Scientific, LLC.
• 4. Becton, Dickinson and Company.
• 5. Bio-Rad Laboratories, Inc.
• 6. Bio-Techne Corporation
• 7. bioMerieux, Inc.
• 8. Biotron Diagnostics Inc.
• 9. Danaher Corporation
• 10. ERBA Diagnostics Mannheim
• 11. Euroclone S.p.A.
• 12. Genelinx International, Inc.
• 13. LI-COR, Inc., d/b/a LI-COR Biosciences
• 14. Lonza Group Ltd.
• 15. Merck KGaA
• 16. Promega Corporation
• 17. ProteoChem, Inc.
• 18. Quality Biological, Inc.
• 19. Revvity, Inc.
• 20. Siemens Healthineers AG
• 21. Sysmex Asia Pacific Pte Ltd.
• 22. Takara Bio USA, Inc.
• 23. Thermo Fisher Scientific Inc.
• 24. Viagen Biotech, Inc.
• 25. Waters Corporation